Servier’s brain tumour treatment approved by US FDA
Servier Pharmaceuticals said the US FDA approved its treatment for a type of brain tumour, becoming the first drug to gain approval in the US for the disease. The drug, known as voranigo, is used to treat a form of brain cancer, called IDH-mutated grade 2 glioma, in patients who have undergone surgery.
ENTRADAS POPULARES
Bluetongue outbreak in a Portuguese sheep farm has broken out
septiembre 19, 2024
Austria says disaster fund to rise to 1 billion euros
septiembre 19, 2024
Portugal gets help from Spain and Morocco in response to fires
septiembre 19, 2024
Drought reduces Amazon rivers to historic lows
septiembre 19, 2024
TRANSMISIÓN EN VIVO